Effect of a network system for providing proper inhalation technique by community pharmacists on clinical outcomes in COPD patients

International Journal of COPD

Volumn 8, Issue , 2013, Pages 239-244

  Takemura, Masaya ^a   Mitsui, Katsumi ^a   Ido, Masako ^a   Matsumoto, Masataka ^a   Koyama, Misuzu ^b   Inoue, Daiki ^a   Takamatsu, Kazufumi ^a   Itotani, Ryo ^a   Ishitoko, Manabu ^a   Suzuki, Shinko ^a   Aihara, Kensaku ^a   Sakuramoto, Minoru ^a   Kagioka, Hitoshi ^a   Fukui, Motonari ^a  

^a Kitano Hospital   (Japan)

^b Kita ku Pharmaceutical Association   (Japan)

Author keywords

Adherence; Community pharmacist; COPD; Exacerbation; Quality of life

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY PHARMACIST; DISEASE CONTROL; DISEASE EXACERBATION; FEMALE; HEALTH CARE DELIVERY; HEALTH STATUS; HUMAN; LIKERT SCALE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACIST; PROSPECTIVE STUDY; QUALITY OF LIFE;

ADHERENCE; COMMUNITY PHARMACIST; COPD; EXACERBATION; QUALITY OF LIFE;

AGED; BRONCHODILATOR AGENTS; COMPUTER-ASSISTED INSTRUCTION; FEMALE; HUMANS; JAPAN; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; OUTCOME ASSESSMENT (HEALTH CARE); OUTPATIENTS; PATIENT EDUCATION AS TOPIC; PHARMACISTS; PROFESSIONAL ROLE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY IMPROVEMENT; QUALITY OF LIFE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; RESPIRATORY THERAPY;

EID: 84877709731     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S44022     Document Type: Article

References (30)

1. National Institutes of Health. NHLBI/WHO Workshop Report: National Institutes of Health, National Heart, Lung and Blood Institute, Update 2008. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Bethesda, MD: National Institute of Health; 2008.
2. Calverley PM, Anderson JA, Celli B, et al; for TORCH Investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356(8):775-789.
3. Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15): 1543-1554.
4. Krigsman K, Nilsson JL, Ring L. Adherence to multiple drug therapies: refill adherence to concomitant use of diabetes and asthma/COPD medication. Pharmacoepidemiol Drug Saf. 2007;16(10):1120-1128.
5. Krigsman K, Moen J, Nilsson JL, Ring L. Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period. J Clin Pharm Ther. 2007;32(6):603-611.
6. Haupt D, Krigsman K, Nilsson JL. Medication persistence among patients with asthma/COPD drugs. Pharm World Sci. 2008;30(5):509-514.
7. Molimard M, Raherison C, Lignot S, Depont F, Abouelfath A, Moore N. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med. 2003;16(3): 249-254.
8. Vestbo J, Anderson JA, Calverley PM, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64(11):939-943.
9. Takemura M, Mitsui K, Itotani R, et al. Relationships between repeated instruction on inhalation therapy, medication adherence, and health status in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011;6:97-104.
10. Takemura M, Mitsui K, Ido M, et al. Impact of a network system for providing proper inhalation technique by community pharmacists. J Asthma. 2012;49(5):535-541.
11. Erickson SR, Coombs JH, Kirking DM, Azimi AR. Compliance from self-reported versus pharmacy claims data with metered-dose inhalers. Ann Pharmacother. 2001;35(9):997-1003.
12. De Smet BD, Erickson SR, Kirking DM. Self-reported adherence in patients with asthma. Ann Pharmacother. 2006;40(3):414-420.
13. Takemura M, Kobayashi M, Kimura K, et al. Repeated instruction on inhalation technique improves adherence to the therapeutic regimen in asthma. J Asthma. 2010;47(2):202-208.
14. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986; 24(1):67-74.
15. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348-354.
16. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St George's Respiratory Questionnaire. Am Rev Respir Dis. 1992;145(6): 1321-1327.
17. Bouchet C, Guillemin F, Hoang Thi TH, Cornette A, Briançon S. Validation of the St George's questionnaire for measuring the quality of life in patients with chronic obstructive pulmonary disease. Rev Mal Respir. 1996;13(1):43-46.
18. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(3 Pt 1):785-790.
19. Basheti IA, Reddel HK, Armour CL, Bosnic-Anticevich SZ. Improved asthma outcomes with a simple inhaler technique intervention by community pharmacists. J Allergy Clin Immunol. 2007;119(6):1537-1538.
20. Armour C, Bosnic-Anticevich S, Brillant M, et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax. 2007;62(6):496-502.
21. Mehuys E, Van Bortel L, De Bolle L, et al. Effectiveness of pharmacist intervention for asthma control improvement. Eur Respir J. 2008;31(4): 790-799.
22. Self TH, Brooks JB, Lieberman P, Ryan MR. The value of demonstration and role of the pharmacist in teaching the correct use of pressurized bronchodilators. Can Med Assoc J. 1983;128(2):129-131.
23. McLean W, Gillis J, Waller R. The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Can Respir J. 2003;10(4):195-202.
24. Cordina M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy. 2001;21(10):1196-1203.
25. Barbanel D, Eldridge S, Griffiths C. Can a self-management programme delivered by a community pharmacist improve asthma control? A randomised trial. Thorax. 2003;58(10):851-854.
26. Khdour MR, Kidney JC, Smyth BM, McElnay JC. Clinical pharmacyled disease and medicine management programme for patients with COPD. Br J Clin Pharmacol. 2009;68(4):588-598.
27. Jarab AS, Alqudah SG, Khdour M, Shamssain M, Mukattash TL. Impact of pharmaceutical care on health outcomes in patients with COPD. Int J Clin Pharm. 2012;34(1):53-62.
28. Monninkhof E, van der Valk P, van der Palen J, van Herwaarden C, Partridge MR, Zielhuis G. Self-management education for patients with chronic obstructive pulmonary disease: a systematic review. Thorax. 2003;58(5):394-398.
29. Gallefoss F, Bakke PS, Rsgaard PK. Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159(3):812-817.
30. McGeoch GR, Willsman KJ, Dowson CA, et al. Self-management plans in the primary care of patients with chronic obstructive pulmonary disease. Respirology. 2006;11(5):611-618.